NDC 66794-230
Dexmedetomidine
Dexmedetomidine
Dexmedetomidine is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Piramal Critical Care Inc. The primary component is Dexmedetomidine Hydrochloride.
| Product ID | 66794-230_b93a71ed-0f9f-1ff9-e053-2995a90a789d |
| NDC | 66794-230 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexmedetomidine |
| Generic Name | Dexmedetomidine |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-01-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202126 |
| Labeler Name | Piramal Critical Care Inc |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Active Ingredient Strength | 200 ug/2mL |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],General Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |